Management of Liver Cancer in Ayurveda With Therapeutic Purgation and Rectal administration with Ayurvedic Drugs.

COMPARATIVE CLINICAL STUDY OF VIRECHAN WITH NARAYAN CHURN & BHADRADI ASTHAPAN BASTI IN THE MANAGEMENT OF YAKRITARBUD (HEPATOCELLULAR CARCINOMA)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036106

Enrollment

Registered

2021-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are Virechan and Basti Yogya Patients Diagnosed with stage I, II, III Hepatocellular Carcinoma.

Exclusion criteria

Exclusion criteria: Patients of Advanced stages of HCC Extra Hepatic Metastasis Patients with Ascites and Pleural Effusion Very Debilitated patients Any cardiac disease and renal disorders. Patient having other associated diseases like Anorectal disorders, HIV positive, Tuberculosis, Malaria, Asthma & Diabetes etc.

Design outcomes

Primary

Measure	Time frame
Subective Criteria Scoring system ECOG performance status RECIST responce evaluation criteria in solid tumour Objective Criteria signs of samyak Virechan karma & Basti karma BP,PULSE,temperature INVESTIGATION Carcinogen Embryonic Antigen CEA Alpha Feto Protein CBC LFT RFT HBSAg CT scan if needed Ultra Sonography Timepoint: 45 Days	—

Secondary

Measure	Time frame
To find out the comparative efficacy of the treatment in all three groups with the help of scoring system, signs of samyak virechan and basti karma and blood profileTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Gyan Prkash Sharma

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

atreyagyan@gmail.com9829798701

Outcome results